ELEVANCE HEALTH, INC. (ELV) Profit Breakdown
- 2026-06-30: Reportable Segments $1.76B; Total Carelon $948.00M; Health Benefits $896.00M; CarelonRx $582.00M.
- 2025-06-30: Reportable Segments $2.42B; Total Carelon $936.00M; Health Benefits $1.56B; CarelonRx $536.00M.
Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.
- Available history
- 2007-12-31 to 2026-06-30
- Data captured
Profit by product
Operating income: each quarter (3 month)
| Quarter end | Reportable Segments | Total Carelon | Health Benefits | CarelonRx | Carelon Services |
|---|
| 2026-06-30 | $1.76B | $948.00M | $896.00M | $582.00M | $366.00M |
|---|
| 2025-06-30 | $2.42B | $936.00M | $1.56B | $536.00M | $400.00M |
|---|
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest: each quarter (3 month)
| Quarter end | Reportable Segments |
|---|
| 2026-06-30 | $1.94B |
|---|
| 2025-06-30 | $2.29B |
|---|